skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Free E-Journal (出版社公開部分のみ） remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab
Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab
Material Type:
Artigo 		Adicionar ao Meu Espaço

Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab

Ruyssen-Witrand, A ; Rouanet, S ; Combe, B ; Dougados, M ; Le Loët, X ; Sibilia, J ; Tebib, J ; Mariette, X ; Constantin, A

Annals of the rheumatic diseases, 2012-06, Vol.71 (6), p.875-877 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd and European League Against Rheumatism

Texto completo disponível

Citações Citado por
2
THU0063 Does biologic treatment modify the relationship of the variables associated with fatigue in patients with rheumatoid arthritis? The peps study of tocilizumab in real life
THU0063 Does biologic treatment modify the relationship of the variables associated with fatigue in patients with rheumatoid arthritis? The peps study of tocilizumab in real life
Material Type:
Artigo 		Adicionar ao Meu Espaço

THU0063 Does biologic treatment modify the relationship of the variables associated with fatigue in patients with rheumatoid arthritis? The peps study of tocilizumab in real life

Gossec, L. ; Rouanet, S. ; Steinberg, G. ; Combe, B.

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.174-174 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd and European League Against Rheumatism

Texto completo disponível

Citações Citado por
3
THU0087 One single infusion of rituximab 1g might be sufficient in the long-term management of rheumatoid arthritis patients responding to a first cycle of rituximab (2 × 1g): Results of a 2-year multi-center randomized controlled trial
THU0087 One single infusion of rituximab 1g might be sufficient in the long-term management of rheumatoid arthritis patients responding to a first cycle of rituximab (2 × 1g): Results of a 2-year multi-center randomized controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

THU0087 One single infusion of rituximab 1g might be sufficient in the long-term management of rheumatoid arthritis patients responding to a first cycle of rituximab (2 × 1g): Results of a 2-year multi-center randomized controlled trial

Dougados, M. ; Combe, B. ; Le Loët, X. ; Tebib, J. ; Sibilia, J. ; Rouanet, S. ; Jourdan, R. ; Mariette, X.

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.182-182 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd and European League Against Rheumatism

Texto completo disponível

Citações Citado por
4
SAT0111 Description of Glucocorticoid Sparing Effect in Rheumatoid Arthritis (RA) Patients Treated by Tocilizumab (TCZ) in Real Life: An Interim Analysis of the Spare-1 Study
SAT0111 Description of Glucocorticoid Sparing Effect in Rheumatoid Arthritis (RA) Patients Treated by Tocilizumab (TCZ) in Real Life: An Interim Analysis of the Spare-1 Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

SAT0111 Description of Glucocorticoid Sparing Effect in Rheumatoid Arthritis (RA) Patients Treated by Tocilizumab (TCZ) in Real Life: An Interim Analysis of the Spare-1 Study

Saraux, A. ; Rouanet, S. ; Flipo, R.-M. ; Poncet, J.-C. ; Fardellone, P. ; Contré, C. ; Cantagrel, A.

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A618-A618 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd and European League Against Rheumatism

Texto completo disponível

Citações Citado por
5
FRI0247 Serum level of interleukin 33, a novel independent predictive biomarker of clinical response to rituximab in rheumatoid arthritis: results from the smart trial
FRI0247 Serum level of interleukin 33, a novel independent predictive biomarker of clinical response to rituximab in rheumatoid arthritis: results from the smart trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

FRI0247 Serum level of interleukin 33, a novel independent predictive biomarker of clinical response to rituximab in rheumatoid arthritis: results from the smart trial

Sellam, J. ; Rouanet, S. ; Hendel-Chavez, H. ; Marion-Thore, S. ; Miceli-Richard, C. ; Combe, B. ; Sibilia, J. ; Le Loët, X. ; Tebib, J. ; Chiocchia, G. ; Jourdan, R. ; Dougados, M. ; Taoufik, Y. ; Mariette, X.

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A457-A457 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd and European League Against Rheumatism

Texto completo disponível

Citações Citado por
6
THU0107 CCL19, a chemokine involved in B-cell trafficking, is related to the decrease of blood memory B-cells and predicts the clinical response to rituximab in rheumatoid arthritis: Results from the smart study
THU0107 CCL19, a chemokine involved in B-cell trafficking, is related to the decrease of blood memory B-cells and predicts the clinical response to rituximab in rheumatoid arthritis: Results from the smart study
Material Type:
Artigo 		Adicionar ao Meu Espaço

THU0107 CCL19, a chemokine involved in B-cell trafficking, is related to the decrease of blood memory B-cells and predicts the clinical response to rituximab in rheumatoid arthritis: Results from the smart study

Sellam, J. ; Rouanet, S. ; Hendel-Chavez, H. ; Abbed, K. ; Combe, B. ; Sibilia, J. ; Le Loët, X. ; Tebib, J. ; Jourdan, R. ; Dougados, M. ; Taoufik, Y. ; Mariette, X.

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.190-190 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd and European League Against Rheumatism

Texto completo disponível

Citações Citado por
7
PMS42 CONTENT VALIDITY AND HEALTH CARE SYSTEMS: A CASE-STUDY
PMS42 CONTENT VALIDITY AND HEALTH CARE SYSTEMS: A CASE-STUDY
Material Type:
Artigo 		Adicionar ao Meu Espaço

PMS42 CONTENT VALIDITY AND HEALTH CARE SYSTEMS: A CASE-STUDY

Gagol, G ; Fernandez, N ; Rouanet, S

Value in health, 2011, Vol.14 (3), p.A130-A131 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
8
Results of a study evaluating patient's perception regarding their erythropoiesis stimulating agent treatment in chronic kidney disease using a choice based conjoint analysis
Results of a study evaluating patient's perception regarding their erythropoiesis stimulating agent treatment in chronic kidney disease using a choice based conjoint analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Results of a study evaluating patient's perception regarding their erythropoiesis stimulating agent treatment in chronic kidney disease using a choice based conjoint analysis

Pau, D ; Choukroun, G ; Moranne, O ; Vigneau, C ; Isnard-Bagnis, C ; Boutry, X ; Gokou, S ; Rouanet, S ; Triglia, A

Value in health, 2013-05, Vol.16 (3), p.A182-A183 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
9
Impact of the antiplatelet strategy following patent foramen ovale percutaneous closure
Impact of the antiplatelet strategy following patent foramen ovale percutaneous closure
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of the antiplatelet strategy following patent foramen ovale percutaneous closure

Guedeney, P ; Farjat-Pasos, J I ; Asslo, G ; Roule, V ; Hermida, A ; Huang, F ; Lattuca, B ; Leclercq, F ; Mesnier, J ; Abtan, J ; Rouanet, S ; Zeitouni, M ; Silvain, J ; Montalescot, G ; Rodes-Cabau, J

European heart journal, 2023-11, Vol.44 (Supplement_2) [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
10
STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry)
STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry)
Material Type:
Artigo 		Adicionar ao Meu Espaço

STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry)

Montalescot, Gilles ; Dallongeville, Jean ; Van Belle, Eric ; Rouanet, Stephanie ; Baulac, Cathrine ; Degrandsart, Alexia ; Vicaut, Eric

European heart journal, 2007-06, Vol.28 (12), p.1409-1417 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (475)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (495)
  2. Reports  (3)
  3. Anais de Congresso  (3)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1990  (11)
  2. 1990Até1998  (33)
  3. 1999Até2006  (83)
  4. 2007Até2015  (163)
  5. Após 2015  (212)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (446)
  2. Francês  (47)
  3. Japonês  (45)
  4. Português  (9)
  5. Espanhol  (2)
  6. Alemão  (1)
  7. Norueguês  (1)
  8. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.